###begin article-title 0
###xml 62 67 <span type="species:ncbi:9606">Human</span>
Regulation of the High Affinity IgE Receptor (FcepsilonRI) in Human Neutrophils: Role of Seasonal Allergen Exposure and Th-2 Cytokines
###end article-title 0
###begin p 1
###xml 271 279 <span type="species:ncbi:9606">patients</span>
Conceived and designed the experiments: AG. Performed the experiments: MA AS LS. Analyzed the data: AG MA AS LS KH. Contributed reagents/materials/analysis tools: FS KH. Wrote the paper: FS AG MA. Other: Characterization of the allergic asthmatic, allergic non asthmatic patients: FS. Wrote the first draft of the result part: MA.
###end p 1
###begin p 2
###xml 158 163 <span type="species:ncbi:9606">human</span>
###xml 1250 1255 <span type="species:ncbi:9606">human</span>
The high affinity IgE receptor, FcepsilonRI, plays a key role in the immunological pathways involved in allergic asthma. Previously we have demonstrated that human neutrophils isolated from allergic asthmatics express a functional FcepsilonRI, and therefore it was of importance to examine the factors regulating its expression. In this study, we found that neutrophils from allergic asthmatics showed increased expression of FcepsilonRI-alpha chain surface protein, total protein and mRNA compared with those from allergic non asthmatics and healthy donors (p<0.001). Interestingly, in neutrophils isolated from allergic asthmatics, FcepsilonRI-alpha chain surface protein and mRNA expression were significantly greater during the pollen season than outside the pollen season (n = 9, P = 0.001), an effect which was not observed either in the allergic non asthmatic group or the healthy donors (p>0.05). Allergen exposure did not affect other surface markers of neutrophils such as CD16/FcgammaRIII or IL-17R. In contrast to stimulation with IgE, neutrophils incubated with TH2 cytokines IL-9, GM-CSF, and IL-4, showed enhanced FcepsilonRI-alpha chain surface expression. In conclusion, these results suggest that enhanced FcepsilonRI expression in human neutrophils from allergic asthmatics during the pollen season can make them more susceptible to the biological effects of IgE, providing a possible new mechanism by which neutrophils contribute to allergic asthma.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 273 276 273 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Holgate1">[1]</xref>
###xml 278 281 278 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-OByrne1">[2]</xref>
###xml 471 474 471 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Bradley1">[3]</xref>
Asthma is a chronic inflammatory disease of the bronchial airways which has been increasing in prevalence during the last four decades. Airway inflammation is a major factor in the pathogenesis of asthma, in associated bronchial hyperresponsiveness and in disease severity [1], [2]. The inflammatory component of this disease includes an increased number of activated T lymphocytes, mast cells, neutrophils and eosinophils within the airway lumen and bronchial submucosa [3].
###end p 4
###begin p 5
###xml 492 495 492 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Nocker1">[4]</xref>
###xml 497 500 497 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Fahy1">[5]</xref>
###xml 502 505 502 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Kelly1">[6]</xref>
###xml 710 713 710 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Ennis1">[7]</xref>
###xml 715 718 715 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Ordonez1">[8]</xref>
###xml 720 723 720 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Nguyen1">[9]</xref>
###xml 892 895 892 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Ennis1">[7]</xref>
###xml 193 201 <span type="species:ncbi:9606">patients</span>
###xml 366 374 <span type="species:ncbi:9606">patients</span>
Many studies support the concept that neutrophils may significantly contribute to chronic inflammation and alterations in airway structure that characterize asthma. After allergen challenge of patients with allergic asthma, neutrophils are the first inflammatory cells to accumulate within the airways and neutrophil numbers in bronchoalveolar lavage (BAL) fluid of patients with allergic asthma after allergen challenge have been calculated to be about 90 times higher than healthy controls [4], [5], [6]. Furthermore, an increase of airway neutrophils was also detected in induced sputum from adults with acute exacerbations of severe asthma, and in bronchial biopsies of severe steroid resistant asthmatics [7], [8], [9]. Circulating neutrophils are activated during active asthma, after exercise-induced bronchospasm and during both early and late asthmatic reactions induced by allergen [7].
###end p 5
###begin p 6
###xml 95 99 95 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Burrows1">[10]</xref>
###xml 271 275 271 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Peebles1">[11]</xref>
###xml 385 389 385 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Peebles2">[12]</xref>
###xml 376 384 <span type="species:ncbi:9606">patients</span>
IgE has long been regarded as a major molecular component of atopic diseases, including asthma [10]. Clinical studies have found a close association between allergic asthma and elevated serum specific IgE levels as well as IgE dependent skin test reactivity to allergens [11]. In addition, allergen specific IgE has been detected in bronchoalveolar lavage fluids in asthmatic patients [12].
###end p 6
###begin p 7
###xml 114 118 108 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Kinet1">[13]</xref>
###xml 276 280 270 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Kinet1">[13]</xref>
###xml 582 586 570 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Gounni1">[14]</xref>
###xml 588 592 576 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Maurer1">[15]</xref>
###xml 594 598 582 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Maurer2">[16]</xref>
###xml 600 604 588 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Novak1">[17]</xref>
###xml 606 610 594 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Campbell1">[18]</xref>
###xml 355 360 <span type="species:ncbi:9606">human</span>
###xml 419 427 <span type="species:ncbi:9606">patients</span>
The high affinity receptor for IgE (FcepsilonRI) is a key structure involved in immediate allergic manifestations [13]. Initially discovered on mast cells and basophils whose function is to mediate cellular degranulation and the release of various mediators such as histamine [13], FcepsilonRI has been later detected on many inflammatory cells including human cutaneous Langerhans cells, dendritic cells, monocytes of patients with a number of allergic disorders, on eosinophils from subjects with hypereosinophilic syndrome or asthma, on platelets, and bronchial epithelial cells [14], [15], [16], [17], [18].
###end p 7
###begin p 8
###xml 103 107 97 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Gounni2">[19]</xref>
###xml 727 735 699 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 31 36 <span type="species:ncbi:9606">human</span>
###xml 202 207 <span type="species:ncbi:9606">human</span>
###xml 240 245 <span type="species:ncbi:9606">human</span>
Recently, we demonstrated that human neutrophils isolated from allergic asthmatics express FcepsilonRI [19] and thus, it was of importance to examine the factors regulating expression of FcepsilonRI in human neutrophils. Here, we show that human neutrophils from allergic asthmatics express high levels of FcepsilonRI compared with allergic non asthmatics and healthy donors. Furthermore, natural seasonal allergen exposure up-regulates FcepsilonRI expression at mRNA and cell surface levels in neutrophils of allergic asthmatics but not in allergic non asthmatics or healthy donors. This effect is selective since seasonal allergen exposure did not alter surface markers of neutrophil such as FcgammaRIII/CD16. Interestingly, in vitro stimulation with TH-2 cytokines including IL-9, GM-CSF and IL-4 induced elevated FcepsilonRI expression in neutrophils from allergic asthmatics.
###end p 8
###begin title 9
Results
###end title 9
###begin title 10
###xml 39 44 <span type="species:ncbi:9606">human</span>
Increased expression of FcepsilonRI in human neutrophils from allergic asthmatics compared to non asthmatic allergic and healthy individuals
###end title 10
###begin p 11
###xml 115 119 109 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Gounni2">[19]</xref>
###xml 327 334 309 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 671 683 631 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001921-g001">Figure 1A, B</xref>
###xml 1039 1048 989 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001921-g001">Figure 1F</xref>
###xml 175 180 <span type="species:ncbi:9606">human</span>
Expression of FcepsilonRI by cells other than mast cells was previously reported, as was expression in neutrophils [19]. To investigate the level of FcepsilonRI expression in human neutrophils from allergic asthmatic, allergic non asthmatic and healthy individuals, we first analyzed FcepsilonRI mRNA expression by fluorescent in situ hybridization (FISH) using anti-sense FcepsilonRI-alpha chain riboprobe. Neutrophils from allergic asthmatics showed an increase in FcepsilonRI mRNA expression (mean percentage of positive cells 63.2+/-10.21%, n = 19) compared with allergic non asthmatic (22.9+/-8.08%, n = 18) or healthy individuals (10.14+/-6.25 %, n = 21) (p<0.001, Figure 1A, B). No specific signal could be detected with sense riboprobe used as negative control (data not shown). Furthermore, real-time RT-PCR analysis showed a significant increase of FcepsilonRIalpha chain mRNA in neutrophils from allergic asthmatics (n = 7) compared with healthy individuals (n = 10, p = 0.0046), but not allergic non asthmatics (n = 6, p>0.05, Figure 1F). Moreover, neutrophils from allergic asthmatics express 1000 to 300 times less FcepsilonRI-alpha mRNA compared to basophilic cell line KU812 (relative mean copy number in KU812 = 737+/-134/GAPDH copy, n = 3).
###end p 11
###begin title 12
Upregulated FcepsilonRI alpha chain mRNA and surface expression in neutrophils from allergic asthmatics.
###end title 12
###begin p 13
###xml 241 248 231 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
Neutrophils FcepsilonRI alpha chain mRNA and surface expression in allergic asthmatics, allergic non asthmatics and healthy subjects were determined by FISH (A,B) real-time RT-PCR (F) and flow cytometry (C, D), respectively, as described in Methods. E. FcgammaRIII/CD16 surface expression on neutrophils of the same subjects in A and C. , *p<0.0001, **p<0.01, ns: non significant. P values were calculated using Mann Whitney U test. IC mAb: isotype control. Example of cells with positive (one asterisk) and negative (two asterisks) signal in FISH are indicated in panel A.
###end p 13
###begin p 14
###xml 196 200 180 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Nechansky1">[20]</xref>
###xml 297 306 281 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001921-g001">Figure 1E</xref>
###xml 627 639 593 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001921-g001">Figure 1C, D</xref>
###xml 856 865 816 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001921-g001">Figure 1B</xref>
To confirm that neutrophils from allergic asthmatics expressed FcepsilonRI at cell surface, flow cytometry analysis using mAb directed against the FcepsilonRI alpha chain, the IgE binding subunit [20], was performed. Neutrophils from allergic asthmatics, which express the neutrophil marker CD16 (Figure 1E), showed an increase in FcepsilonRI surface expression (% of positive cells 47.67+/-5.46%; Mean fluorescence intensity (MFI) = 49.5+/-12.37, n = 17) compared with neutrophils from allergic non asthmatics (7.74+/-4.41%; MFI = 3.54+/-2.3; n = 15) and healthy individuals (6.23+/-3.39%; MFI = 0.65+/-0.3; n = 16) (p<0.001, Figure 1C, D). Interestingly, we found that neutrophils express between 1.3 to 10 times less FcepsilonRI surface receptor compared with basophilic cell line (KU812) by using quantitative indirect immunofluorescence (Supplemental Figure 1B). We further analyzed the same samples by immuno-fluorescence and found an increase in FcepsilonRI protein expression in neutrophils from allergic asthmatics (% of positive cells: 86.92+/-9.03 %; n = 10) compared with allergic non asthmatics (28.82+/-13.47%; n = 11) and healthy donors (0.4+/-0.5; n = 11).
###end p 14
###begin title 15
###xml 78 83 <span type="species:ncbi:9606">human</span>
Allergen exposure during pollen season up-regulates FcepsilonRI expression by human neutrophils from allergic asthmatics
###end title 15
###begin p 16
###xml 554 566 532 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001921-g002">Figure 2A, B</xref>
###xml 704 717 672 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001921-g002">Figure 2 C, D</xref>
###xml 131 136 <span type="species:ncbi:9606">human</span>
###xml 362 367 <span type="species:ncbi:9606">human</span>
We then investigated whether allergen exposure during the pollen season can account for the increased expression of FcepsilonRI in human neutrophils from allergic asthmatics. FcepsilonRI expression was tested in and out of the pollen season in neutrophils from the same allergic asthmatics, non allergic asthmatics and healthy donors. Flow cytometry analysis of human neutrophils from allergic asthmatics showed an increase in FcepsilonRI surface expression during the pollen season (57.37+/-18.7 during versus 18.8+/-14.5 out of season, n = 9, P<0.001, Figure 2A, B). FISH and immunofluorescence analysis revealed a similar pattern with an increase of FcepsilonRI alpha chain mRNA positive neutrophils (Figure 2 C, D) and FcepsilonRI-alpha chain immuno-positive neutrophils (data not shown) during the pollen season compared with neutrophils obtained out of the pollen season.
###end p 16
###begin title 17
###xml 73 78 <span type="species:ncbi:9606">human</span>
Effect of pollen season on surface and mRNA expression of FcepsilonRI in human neutrophils.
###end title 17
###begin p 18
###xml 239 240 229 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 111 116 <span type="species:ncbi:9606">human</span>
FcepsilonRI alpha chain surface (A, B) and mRNA expression (C, D) are up-regulated during the pollen season in human neutrophils from allergic asthmatics, but not in allergic non asthmatics or healthy donors. *p<0.01, ns: non significant. P values were calculated using Wilcoxon signed rank test. (E, F) represent CD16 surface expression in neutrophils from the same subjects as in (A, B) and (C-D).
###end p 18
###begin p 19
###xml 343 354 329 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001921-g002">Figure 2E&#8211;F</xref>
###xml 629 644 609 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001921-g002">Figure 2B and D</xref>
###xml 150 155 <span type="species:ncbi:9606">human</span>
###xml 549 554 <span type="species:ncbi:9606">human</span>
To confirm that seasonal allergen exposure selectively affected FcepsilonRI expression in neutrophils from allergic asthmatics, surface expression of human neutrophil markers FcgammaRIII/CD16 and IL-17AR was investigated by FACS in neutrophils isolated from the same allergic asthmatic subjects. As detected by FACS analysis FcgammaRIII/CD16 (Figure 2E-F) and IL-17R (data not shown) expression was stable during and out of the pollen season (p>0.05). Furthermore, seasonal allergen exposure did not affect FcepsilonRI surface or mRNA expression by human neutrophils from allergic non asthmatics and healthy individuals (p>0.05, Figure 2B and D).
###end p 19
###begin title 20
Effect of TH-2 cytokines on FcepsilonRI expression in neutrophils from allergic asthmatics
###end title 20
###begin p 21
###xml 232 240 220 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 561 569 533 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001921-g003">Figure 3</xref>
###xml 842 850 794 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001921-g003">Figure 3</xref>
###xml 1170 1185 1106 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001921-g004">Figure 4A and B</xref>
###xml 1484 1493 1388 1397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001921-g004">Figure 4C</xref>
###xml 122 127 <span type="species:ncbi:9606">human</span>
###xml 646 651 <span type="species:ncbi:9606">human</span>
###xml 1100 1105 <span type="species:ncbi:9606">human</span>
To investigate the potential mechanism through which seasonal allergen exposure might influence FcepsilonRI expression in human neutrophils from allergic asthmatics, we studied the effect of Th-2 cytokines on FcepsilonRI expression in vitro. Expression of FcepsilonRI mRNA and protein was analyzed following stimulation with IL-4, IL-9 or GM-CSF for 6hr. The number of FcepsilonRI-alpha chain mRNA copies was consistently higher in IL-9 or GM-CSF stimulated cells than in unstimulated neutrophils, as measured by real-time RT-PCR in three separate experiments (Figure 3). Although IL-4 seems to enhance FcepsilonRI alpha chain mRNA expression in human neutrophils it did not reach significance (p>0.05). Moreover, stimulation with IFN-gamma decreased the expression of FcepsilonRI mRNA in neutrophils from allergic asthmatics (n = 3, P<0.05, Figure 3). We then confirmed the effect of TH-2 cytokines on FcepsilonRI expression at the surface and intracellular protein level. As detected by flow cytometry, IL-4, GM-CSF and IL-9 up-regulated significantly FcepsilonRI alpha chain surface expression in human neutrophils from allergic asthmatic individuals (n = 4, p<0.05, Figure 4A and B). Furthermore, in contrast to medium treated cells, significant up-regulation of FcepsilonRI-alpha chain 45approximately48 kDa was detected in IL-9, IL-4 and GM-CSF stimulated neutrophils as detected by immunoprecipitation with IgE/anti IgE and Western blot using anti-FcepsilonRI alpha chain mAb (Figure 4C, n = 3).
###end p 21
###begin title 22
###xml 64 69 <span type="species:ncbi:9606">human</span>
TH-2 cytokines up-regulate FcepsilonRI alpha mRNA expression in human neutrophils isolated from allergic asthmatics.
###end title 22
###begin p 23
Neutrophils from three different asthmatics stimulated with IL-9, IL-4, or GM-CSF (10ng/ml) for 6h showed increased mRNA expression of FcepsilonRI alpha chain as determined by Real-time RT-PCR. Data represents the mean+/-SEM of three independent experiments performed under the same condition. * P<0.05 compared with medium alone and were calculated using Mann Whitney U test.
###end p 23
###begin title 24
TH-2 cytokines induce FcepsilonRI alpha chain surface expression in neutrophils from allergic asthmatics.
###end title 24
###begin p 25
###xml 602 609 576 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
A. Representative FACS data of FcepsilonRI alpha chain surface expression in neutrophil stimulated with IL-9, IL-4, or GM-CSF (all at 10ng/ml) for 18hrs. FACS was performed using mAb anti-FcepsilonRI alpha chain (CRA-1). B. Each point represents mean+/-SEM values from four allergic asthmatic donors. Results are expressed as MFI of CRA-1 minus MFI of isotype control mAb (DeltaMFI). * P<0.05 compared with with medium alone and were calculated using Mann Whitney U test. (C) Total protein lysates were subjected to immunoprecipitation with IgE/anti IgE and Western blotting with CRA-1 as described in Methods. Basophilic cell line (KU812) was used as positive control. Negative control corresponds to neutrophil protein lysate analyzed without IgE/anti-IgE immunoprecipitation. Data in C is representative of three separate experiments.
###end p 25
###begin title 26
Discussion
###end title 26
###begin p 27
###xml 96 100 96 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Burrows1">[10]</xref>
###xml 397 401 385 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Gounni2">[19]</xref>
###xml 1245 1247 1211 1213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in</italic>
###xml 1335 1343 1295 1303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001921-g003">Figure 3</xref>
###xml 1348 1349 1308 1309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001921-g004">4</xref>
###xml 1562 1566 1522 1526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Saffar1">[21]</xref>
###xml 570 575 <span type="species:ncbi:9606">human</span>
###xml 901 906 <span type="species:ncbi:9606">human</span>
###xml 1188 1193 <span type="species:ncbi:9606">human</span>
IgE has long been regarded as a major molecular component of allergic diseases, including asthma[10]. The effect of IgE is amplified by the activities of the receptors to which it binds. The high affinity receptor for IgE (FcepsilonRI) is a key structure involved in immediate allergic manifestations. Recently, it has become apparent that neutrophils from allergic asthmatics express FcepsilonRI [19]. Although this reveals the capability of these cells to respond to stimuli considered integral to the allergic process, factors that modulate FcepsilonRI expression by human neutrophils have not been investigated. In our study, we have demonstrated that neutrophils from allergic asthmatics have increased FcepsilonRI expression compared with healthy donors or allergic non asthmatics. Interestingly, seasonal allergen exposure selectively enhances the surface and mRNA expression of FcepsilonRI in human neutrophils from allergic asthmatics and not in allergic non asthmatics or healthy donors. Furthermore, neutrophils from all groups showed no change in surface expression of CD16/FcgammaRIII and IL-17R during and out of pollen season. Moreover, TH-2 cytokines, highly expressed in human allergic asthma, mimicked seasonal pollen exposure in vitro and up-regulated FcepsilonRI expression in neutrophils from allergic asthmatics (Figure 3 and 4) but not from allergic non asthmatics or healthy donors (data not shown). Taken together, our data provide a potential new mechanistic explanation of increased neutrophil presence and activity in allergic asthma [21].
###end p 27
###begin p 28
###xml 279 283 273 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Kinet1">[13]</xref>
###xml 549 553 537 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Kinet1">[13]</xref>
###xml 555 559 543 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Campbell1">[18]</xref>
###xml 662 666 644 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Maurer1">[15]</xref>
###xml 717 721 699 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Maurer2">[16]</xref>
###xml 911 918 877 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 1462 1466 1406 1410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Kinet1">[13]</xref>
###xml 325 330 <span type="species:ncbi:9606">human</span>
###xml 374 382 <span type="species:ncbi:9606">patients</span>
###xml 425 433 <span type="species:ncbi:9606">patients</span>
###xml 768 773 <span type="species:ncbi:9606">human</span>
For many years, FcepsilonRI was thought to be exclusively expressed on mast cells and basophils which mediate cellular degranulation and the release of various mediators such as histamine, leukotrienes and a number of cytokines and chemokines, the hallmark of allergic reactions [13]. Later, FcepsilonRI was also detected on human cutaneous Langerhans cells, monocytes from patients with allergic disorders, eosinophils from patients with hypereosinophilic syndrome or asthma, on platelets, circulating dendritic cells and bronchial epithelial cells[13], [18]. FcepsilonRI expressed on monocytes and circulating dendritic cells was shown to mediate calcium flux [15], and to promote IgE mediated antigen presentation [16]. We assessed the expression of FcepsilonRI in human neutrophils among the three groups of individuals in two ways. First, we determined the mRNA expression of FcepsilonRI-alpha chain using in situ hybridization. Second, we compared surface and total protein expression of FcepsilonRI-alpha chain using flow cytometry and immunofluorescence, respectively. These analyses showed that neutrophils in allergic asthmatics but not in allergic non asthmatics or healthy individuals expressed high levels of mRNA, surface and intracellular protein FcepsilonRI. In accordance with our results, high levels of FcepsilonRI expression have been observed in monocytes, eosinophils and Langerhans cell from allergic subjects compared with healthy donors [13]. Interestingly, heterogeneity in FcepsilonRI expression is observed within neutrophils from allergic asthmatic at the level of both mRNA and protein, suggesting that FcepsilonRI expression in neutrophils is highly regulated.
###end p 28
###begin p 29
###xml 239 246 227 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 273 281 261 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001921-g002">Figure 2</xref>
###xml 325 330 <span type="species:ncbi:9606">human</span>
We then investigated whether seasonal exposure to allergen affects FcepsilonRI in neutrophils from the three groups. Our data clearly demonstrated specific up-regulation of FcepsilonRI at the mRNA and protein level in neutrophils isolated ex vivo during the pollen season (Figure 2). Expression of other surface receptors by human neutrophils was not affected, suggesting that FcepsilonRI may play a role in allergic asthma during pollen season.
###end p 29
###begin p 30
###xml 61 68 55 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 73 81 67 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 183 187 171 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Malveaux1">[22]</xref>
###xml 189 193 177 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Yamaguchi1">[23]</xref>
###xml 436 440 424 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Quarto1">[24]</xref>
###xml 442 446 430 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Furuichi1">[25]</xref>
###xml 580 584 562 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Yamaguchi1">[23]</xref>
###xml 586 590 568 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Yano1">[26]</xref>
###xml 592 596 574 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Lantz1">[27]</xref>
###xml 732 736 714 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Kinet1">[13]</xref>
###xml 830 838 806 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 894 901 870 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 901 905 877 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Yamaguchi2">[28]</xref>
###xml 939 947 915 923 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1071 1080 1041 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001921.s001">Figure S1</xref>
###xml 1371 1375 1335 1339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-MacGlashan1">[29]</xref>
###xml 1377 1381 1341 1345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-MacGlashan2">[30]</xref>
###xml 543 548 <span type="species:ncbi:9606">human</span>
###xml 564 569 <span type="species:ncbi:10090">mouse</span>
###xml 768 772 <span type="species:ncbi:10090">mice</span>
###xml 1019 1024 <span type="species:ncbi:9606">human</span>
###xml 1355 1360 <span type="species:ncbi:9606">human</span>
Studies that have investigated the regulation of FcepsilonRI in vivo and in vitro, have shown a correlation between the serum IgE level and FcepsilonRI expression on the cell surface [22], [23]. Two hypotheses have been proposed to explain the basis of this correlation. Either a common factor was capable of regulating the level of both serum IgE and IgE receptors, or the number of receptors was modulated by serum IgE concentrations [24], [25]. Subsequent studies have demonstrated that monomeric IgE up-regulates FcepsilonRI expression on human mast cells and mouse basophils [23], [26], [27]. The proposed mechanism of this up regulation is that IgE protects the cell bound receptors from degradation during receptor recycling [13]. Mast cells from IgE deficient mice express low levels of FcepsilonRI unless up-regulated by in vitro incubation of these cells with IgE or injection of IgE in vivo[28]. However, our data revealed that in vitro incubation with IgE has no effect on FcepsilonRI surface expression in human neutrophils isolated from allergic asthmatic (Figure S1,A) or allergic non asthmatic individuals (data not shown). This phenomenon may occur through various plausible mechanisms. First, stabilization by IgE, which prevents FcepsilonRI receptor internalization and degradation, may not have occurred in neutrophils, in contrast to human basophils [29], [30]. Second, the preformed pool of FcepsilonRI receptor was possibly not adequately transported to the cell surface. Third, the basal level of FcepsilonRI protein synthesis was not maintained in cultured neutrophils, due to their well documented low transcriptional and translational capacity, thus preventing intracellular pool and cell surface replenishment. Fourth, it may be that IgE prevents FcepsilonRI surface loss within 24 hrs of culture but simultaneous apoptosis occurring in neutrophils with associating membrane changes may disguise this effect. Further in depth studies are needed to address these possibilities.
###end p 30
###begin p 31
###xml 140 144 128 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Yamaguchi2">[28]</xref>
###xml 586 590 558 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Xia1">[31]</xref>
###xml 592 596 564 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Kraft1">[32]</xref>
###xml 598 602 570 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Terada1">[33]</xref>
###xml 955 963 909 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001921-g003">Figure 3</xref>
###xml 1165 1169 1113 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Yamaoka1">[34]</xref>
###xml 101 105 <span type="species:ncbi:10090">mice</span>
###xml 357 362 <span type="species:ncbi:9606">human</span>
###xml 493 498 <span type="species:ncbi:9606">human</span>
###xml 528 536 <span type="species:ncbi:9606">patients</span>
###xml 564 569 <span type="species:ncbi:9606">human</span>
###xml 694 699 <span type="species:ncbi:9606">human</span>
###xml 936 941 <span type="species:ncbi:9606">human</span>
Regulation of FcepsilonRI expression is not entirely dependent on IgE. Mast cells from IgE deficient mice express low levels of FcepsilonRI [28] which suggests that the basal levels are under the control of other regulators. In this study, we have clearly demonstrated that Th-2 cytokines IL-9, GM-CSF and IL-4, upregulate FcepsilonRI protein expression in human neutrophils. These data are in agreement with a positive role of IL-4 and IL-9 in the transcription of FcepsilonRI-alpha chain in human mast cells, eosinophils from patients with atopic dermatitis and human dendritic cells [31], [32], [33]. Interestingly, although IL-4 did significantly increase FcepsilonRI surface expression in human neutrophils it's effect at mRNA level was not consistent which may suggest that IL-4 affects FcepsilonRI expression by a different mechanism than GM-CSF and IL-9. Furthermore, we also demonstrated that GM-CSF upregulates FcepsilonRI in human neutrophils (Figure 3). As a key cytokine with pleotropic activity on neutrophil function, GM-CSF also has the ability to induce other neutrophil surface receptors, including the low affinity IgE receptor CD23/FcepsilonRII [34]. Taken together, our data highlight the fact that Th-2 cytokines directly and indirectly account for the pathophysiologic manifestations of allergy and are involved in inducing FcepsilonRI, hence amplifying the IgE/ IgE receptors network.
###end p 31
###begin p 32
###xml 153 157 147 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Gounni2">[19]</xref>
###xml 159 163 153 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Monteseirin1">[35]</xref>
###xml 255 259 249 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Monteseirin1">[35]</xref>
###xml 261 265 255 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Monteseirin2">[36]</xref>
###xml 267 271 261 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Monteseirin3">[37]</xref>
###xml 435 439 423 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Saffar1">[21]</xref>
###xml 506 513 494 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
In previous studies, we and others have demonstrated that FcepsilonRI dependent activation of neutrophils from allergic asthmatics leads to IL-8 release [19], [35], a potent neutrophilic chemoattractant, as well as proteases that may damage airway mucosa [35], [36], [37]. More recently, we have demonstrated that IgE binding to FcepsilonRI can enhance neutrophil survival in allergic asthmatics by a mitochondrial dependent mechanism [21]. In light of these studies and our present data, we propose that, in vivo, allergen exposure in sensitized asthmatics not only enhances neutrophil recruitment to the site of allergen exposure but also upregulates expression of FcepsilonRI by these cells which may therefore participate in IgE-mediated allergic inflammatory responses.
###end p 32
###begin title 33
Methods
###end title 33
###begin title 34
Subjects
###end title 34
###begin p 35
###xml 845 846 845 846 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1148 1149 1144 1145 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1362 1363 1358 1359 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1384 1385 1380 1381 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1594 1595 1586 1587 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1616 1617 1608 1609 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1866 1867 1851 1852 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1893 1894 1878 1879 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 169 180 <span type="species:ncbi:9606">participant</span>
###xml 1676 1688 <span type="species:ncbi:9606">participants</span>
###xml 1801 1813 <span type="species:ncbi:9606">participants</span>
###xml 1911 1923 <span type="species:ncbi:9606">Participants</span>
This study was approved by the Ethics Committee of the Faculty of Medicine, University of Manitoba, Winnipeg, Canada and written informed consent was obtained from each participant. In response to advertisements, individuals 18-45 years old were recruited in each of three groups: allergic individuals with mild asthma, allergic non-asthmatics, and healthy donors. The clinical diagnosis of allergic asthma was determined by: (i) history of asthma symptoms (wheeze, cough, and/or shortness of breath) during the short (6-8 week long) local grass pollen season, controlled with albuterol as needed; (ii) positive epicutaneous test to mixed grass pollen (wheal diameter at least 3 mm more than histamine control wheal) to an epicutaneous test with mixed grass pollen; (iii) 15% or greater improvement in forced expiratory volume in one second (FEV1) after inhalation of albuterol (200 microg) from a metered-dose inhaler. The clinical designation of allergic non-asthmatic was determined by: (i) history of allergic rhinitis symptoms (sneezing, nasal itching, discharge, and/or congestion) during the short local grass pollen season, relieved by an H1-antihistamine as needed; (ii) positive epicutaneous test to mixed grass pollen (wheal diameter at least 3 mm more than histamine control wheal), (iii) no history of asthma symptoms at any time of year, normal FEV1 and no change in FEV1 after albuterol 200 microg from a metered-dose inhaler. The healthy donors had no history of asthma, allergic rhinitis, or other allergic disease, negative epicutaneous tests to mixed grass pollen, normal FEV1 and no change in FEV1 after albuterol 200 microg by metered-dose inhaler. Study participants had not received allergen-specific immunotherapy. For three days before collection of a 40 ml blood sample, all participants refrained from using all medications, including beta2-adrenergic agonists and H1-antihistamines. Participants who reported an upper respiratory tract infection within the previous month were excluded from the study.
###end p 35
###begin title 36
Reagents and antibodies
###end title 36
###begin p 37
###xml 62 63 62 63 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 27 30 <span type="species:ncbi:10116">rat</span>
###xml 36 41 <span type="species:ncbi:10090">mouse</span>
###xml 204 210 <span type="species:ncbi:10090">Murine</span>
###xml 216 221 <span type="species:ncbi:9606">human</span>
###xml 299 305 <span type="species:ncbi:10090">Murine</span>
###xml 345 350 <span type="species:ncbi:10090">mouse</span>
###xml 472 477 <span type="species:ncbi:10090">mouse</span>
###xml 483 488 <span type="species:ncbi:9606">human</span>
###xml 545 550 <span type="species:ncbi:10090">mouse</span>
###xml 756 761 <span type="species:ncbi:9606">human</span>
###xml 891 896 <span type="species:ncbi:10090">mouse</span>
###xml 1136 1142 <span type="species:ncbi:9913">bovine</span>
FITC-conjugated AffiniPure rat anti-mouse IgG (H+L) and F(ab)'2 were obtained from Jackson ImmunoResearch Laboratories (West-Grove, Pennsylvania). Monomeric IgE was purchased from Diateck (Oslo, Norway). Murine anti-human IgE mAb was purchased from BD Biosciences Pharmingen (Mississauga, Ontario). Murine anti-FcepsilonRIalpha chain mAb CRA-1 (mouse IgG1) which recognizes non IgE-binding site was kindly provided by Dr. Chisei Ra, Tokyo University, Japan. FITC labelled mouse anti-human CD16 mAb (Clone 3G8, IgG1), FITC labelled and unlabeled mouse IgG1 isotype control mAb, (clone MOPC21, IgG1) were obtained from Sigma Chemical Co. (Oakville, Ontario). Anti-CD16 mAb immunomagnetic beads were obtained from Miltenyi Biotec (Auburn, Calif). Recombinant human IL-9, IL-4, GM-CSF, and IFN-gamma were purchased from R&D Systems MN). LightCycler-DNA Master SYBR Green I, digoxigenin UTP, and mouse monoclonal anti-digoxiginin were purchased from Roche (Mississauga, Ontario). Ficoll-Paquetrade mark Plus and Dextran 500 were obtained from Amersham Pharmacia Biotech AB (Baie d'Urfe, Quebec). HyQ(R) RPMI 1640 and heat inactivated foetal bovine serum were obtained from Hyclone Laboratories (Logan, Utah). ProLong(R) antifade, propidium iodide, Tyramide Signal Amplification Kit were obtained from (Invitrogen, Carlsabd, CA). Unless stated otherwise, all other reagents were obtained from Sigma Chemical Co.
###end p 37
###begin title 38
Cell preparation and culture
###end title 38
###begin p 39
###xml 81 85 81 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Gounni2">[19]</xref>
###xml 218 219 218 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 311 312 305 306 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 805 809 779 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Gounni2">[19]</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human neutrophils were purified from peripheral blood as we described previously [19]. Viability of the cells was >98% as assessed by trypan blue dye and purity ranged from 96 to 99%. Freshly isolated neutrophils (2x106/ml) from three allergic asthmatic subjects were incubated at 37degreesC in humidified 5% CO2 in RPMI 1640 medium supplemented with 10% heat inactivated FBS and antibiotics for 6 or 18 hrs at 37degreesC with IL-9, IL-4, GM-CSF, or IFN-gamma at a final concentration of 10ng/ml. After culture, cells were washed and either stained for FcepsilonRI-alpha chain surface protein or subjected to RNA isolation and protein extraction for real time RT-PCR and Western blot analysis. Cytospin slides were prepared from freshly isolated or cytokine stimulated neutrophils as previously described [19].
###end p 39
###begin title 40
Flow cytometry
###end title 40
###begin p 41
###xml 109 110 109 110 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 183 185 183 185 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2a</sub>
###xml 221 225 217 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Gounni2">[19]</xref>
###xml 359 360 355 356 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 334 337 <span type="species:ncbi:10116">rat</span>
###xml 343 348 <span type="species:ncbi:10090">mouse</span>
Flow cytometry analysis was performed by incubating freshly isolated or cytokine stimulated neutrophils (1x105) cells for 30 min in PBS/5% FBS with mAb CRA1 or isotype control mAb IgG2a (final concentration 10 microg/ml) [19]. The cells were washed twice with PBS/2%FBS and incubated for 30 min with affinity purified FITC conjugated rat anti-mouse IgG F(ab)'2 (1:200). After washing, cells were fixed with 2% PAF and resuspended in 500 microl of PBS and analyzed on FACScan (Beckman-Coulter Inc., CA). The purity of the neutrophil preparation was also confirmed by staining using FITC labelled anti-CD16 mAb or isotype control IgG1 mAb(1/100 dilution). FACS analysis was done with CellQuest Software (Beckman-Coulter Inc). The results are presented as overlaid histograms and as percentage of positive cells.
###end p 41
###begin title 42
Quantitative indirect immunofluorescence test
###end title 42
###begin p 43
###xml 903 904 893 894 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 988 990 974 976 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2a</sub>
###xml 1165 1166 1147 1148 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1310 1314 1292 1296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-LavabreBertrand1">[38]</xref>
###xml 81 86 <span type="species:ncbi:9606">human</span>
###xml 1140 1143 <span type="species:ncbi:10116">rat</span>
###xml 1149 1154 <span type="species:ncbi:10090">mouse</span>
Quantitative determination of FcepsilonRI alpha chain cell surface expression in human neutrophils and basophilic cell line (KU812) was performed using QIFIT as recommended by the supplier (DakoCytomation, CA). Two beads were used in this protocol. Setup beads were a mixture of blank and high fluorescence beads that were used to establish the fluorescence window of analysis of flow cytometer. The voltage of the fluorescence detector (PMT) was adjusted to make sure that both negative cells and the two populations of beads were displayed simultaneously on the fluorescence scale. The calibration beads were a mixture of beads with well-known numbers of antibody binding sites per bead; fluorescence data corresponding to each of the five bead peaks were used to construct the calibration curve of mean fluorescence intensity (MFI) against binding capacity (ABC). Briefly, neutrophils and KU812 (1x105 /100 microl) were labelled under saturating conditions with mAbCRA-1 or isotype IgG2a control (10 microg/ml). After washing, cells and setup beads and calibration beads were stained, in parallel, with affinity purified FITC conjugated rat anti-mouse IgG F(ab)'2 in saturating amounts (1:200). Cells were analyzed on the flow cytometer and ABC was calculated based on the equation of the calibration curve [38].
###end p 43
###begin title 44
FISH
###end title 44
###begin p 45
###xml 127 131 117 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Gounni2">[19]</xref>
###xml 322 326 312 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Gounni2">[19]</xref>
###xml 1521 1525 1487 1491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001921-Qian1">[39]</xref>
###xml 1652 1653 1616 1617 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</bold>
###xml 529 534 <span type="species:ncbi:4932">yeast</span>
###xml 1019 1024 <span type="species:ncbi:10090">mouse</span>
###xml 1152 1156 <span type="species:ncbi:9925">goat</span>
###xml 1162 1167 <span type="species:ncbi:10090">mouse</span>
###xml 1374 1385 <span type="species:ncbi:3704">horseradish</span>
FcepsilonRI alpha chain probe was generated by RT-PCR and subcloned into pBluescript vector (Stratagene, Mississauga, Ontario) [19]. Vector was linearized with the appropriate enzymes and transcribed with digoxigenin UTP (Roche, Mississauga, Ontario) to generate sense and anti-sense riboprobes as we described previously [19]. For ISH procedures, slides were washed, prehybridized with hybridization buffer (50% Formamide, 5X SSC, 100 microg/ml Heparin, 1X- Denhardt's solution, 0.1% Tween 20, 0.1% CHAPS, 5mM EDTA and 0.3mg/ml yeast tRNA), followed by adding digoxigenin labeled anti-sense probe (1 microg/ml) overnight at 42degreesC. Digoxigenin labelled sense probe was used as negative control. The slides were washed three times with 0.2X SSC for 30 min at 65degreesC and PBT (0.1% Triton X 100, 2 microg/ml BSA, PBS) for 20 min at room temperature. After endogenous peroxide activity blocking, the slides were washed with TNT (0.1M Tris HCl pH7.5, 0.15M NaCl, 0.05% Tween 20) for 5min each at RT, incubated with mouse monoclonal anti-digoxigenin (1:100) for 30min at RT, followed by tyramide signal amplification (TSA) step using HRP conjugated goat anti-mouse IgG (H+L) and Alexa Fluor 488 tyramide as described by the manufacturer (Invitrogen, Carlsabd, CA). TSA is an ultrasensitive molecular morphology detection technique that utilizes the catalytic activity of horseradish peroxidase to generate robust labeling of target nucleic acid sequence or protein in situ in tissue sections or on cells in suspension [39]. Counterstaining was performed with propidium iodide. After washing with PBS, the slides were mounted with ProLong(R) antifade. Images were acquired under oil immersion at 100x magnification by confocal laser scanning microscopy (Olympus IX70 inverted microscope coupled to FluoVIEW confocal laser scanning system with a Cooke Sensicam (Olympus America Inc., Melville, NY). The value of ISH represents the percentage of cells that had a clear signal compared to background signal obtained with the sense probe. This was determined by counting the positive and negative cells, blindfolded for subjects and is the average of three different counts by two different individuals. The background signal represents the number of green dots per cell obtained with sense riboprobe. Cells hybridized with sense riboprobe exhibited no or 1 to 3 green dots as background signal. Cells showing the same number of green dots as obtained with the sense riboprobe are considered negative.
###end p 45
###begin title 46
Confocal laser scanning microscopy and immuno-fluorescence
###end title 46
###begin p 47
###xml 229 231 223 225 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2a</sub>
###xml 412 415 <span type="species:ncbi:10116">rat</span>
###xml 421 426 <span type="species:ncbi:10090">mouse</span>
This was performed by incubating the slides with universal blocking solution (DAKO Diagnostics Canada Inc., Mississauga, ON) for 20 min at RT, followed by overnight incubation at 4degreesC with mAb-CRA1 or isotype control mAb IgG2a (both at 10 microg/ml) prepared in antibody diluting buffer (DAKO Cytomation, Ca). The slides were washed in TBS and incubated with 1:100 dilution of FITC conjugated affinity pure rat anti-mouse IgG (H+L). Nuclear counterstaining and image acquisition was performed as described above. FluoVIEW 2.0 software (Olympus America Inc., Melville, NY) was used to acquire and analyze the confocal images.
###end p 47
###begin title 48
RNA isolation and Real time RT-PCR
###end title 48
###begin p 49
###xml 357 373 343 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Real-Time RT-PCR</italic>
###xml 452 477 419 444 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;CTCCATTACAAATGCCACAGT3&#8242;</named-content>
###xml 481 508 448 475 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;CACGCGGAGCTTTTATTACAGTA3&#8242;</named-content>
###xml 782 812 749 779 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGCAATGCCTCCTGCACCACCAAC-3&#8242;</named-content>
###xml 817 845 784 812 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCGGAGGGGCCATCCACAGTCT-3&#8242;</named-content>
Total cellular RNA was extracted using Trizol (Invitrogen). Reverse transcription (RT) was performed by using 2 microg of total RNA in a first strand cDNA synthesis reaction with SuperScript reverse transcriptase as recommended by the supplier (Invitrogen). The quantification of mRNA of FcepsilonRI-alpha chain expressed by neutrophils was performed using Real-Time RT-PCR by the Light Cycler trade mark . Primer set for FcepsilonRI alpha chain were: 5'CTCCATTACAAATGCCACAGT3'and 5'CACGCGGAGCTTTTATTACAGTA3'. Primers for house-keeping gene glyceraldhyde-3-phosphate dehydrogenase (GAPDH), and standard controls were developed in our laboratory. The forward and reverse specific primer sequences used, the size of the amplified fragment and the annealing temperature for GAPDH are: 5'-AGCAATGCCTCCTGCACCACCAAC-3' and 5'-CCGGAGGGGCCATCCACAGTCT-3', 137 bp, 59degreesC. DNA standards were prepared from PCR using cDNA from cells stimulated by IL-1beta. PCR products were isolated from 0.5% w/v agarose gel using QIAEX II Agarose Gel Extraction kit (Qiagen). The amount of extracted DNA was quantified by spectrophotometry and expressed as copy number. A serial dilution was used to generate each standard curve. PCR was performed by LightCycler-DNA Master SYBR Green I as ready to use reaction mix (Roche). Calculation of the amount of each cDNA species was performed according to manufacturer's standard protocol. Briefly, the amplification of target genes in stimulated cells was calculated by normalizing to the amplification of GADPH gene in the sample.
###end p 49
###begin title 50
Immunoprecipitation and Western blot
###end title 50
###begin p 51
###xml 500 505 <span type="species:ncbi:9606">human</span>
###xml 659 664 <span type="species:ncbi:10090">mouse</span>
###xml 674 679 <span type="species:ncbi:9606">human</span>
###xml 1086 1091 <span type="species:ncbi:10090">mouse</span>
###xml 1208 1212 <span type="species:ncbi:9925">goat</span>
###xml 1218 1223 <span type="species:ncbi:10090">mouse</span>
For protein extraction, neutrophils were lysed for 30 min at 4degreesC in NP-40 lysis buffer supplemented with a cocktail of protease inhibitors (2mM sodium orthovanadate, 1mM phenyl-methylsulfonylfluoride, 10 microg/ml leupeptin, 0.15 units/ml approtinin, 1 microg/ml pepstatin A) (Sigma) and centrifuged for 20 min to remove nuclei. Cell lysates from neutrophils or basophilic cell line (KU812, ATCC(R) # CRL-2099trade mark) used as positive control were sequentially incubated with 2 microg/ml of human IgE (Diateck, Oslo, Norway) for 16 h at 4degreesC in a rotating mixer, followed by protein G sepharose-coated beads (Amersham-Pharmacia) conjugated with mouse mAb anti-human IgE (Pharmingen) for 2h at 4degreesC. Immuno-complexes were pelleted by centrifugation and washed six times with the wash buffer (PBS /1% NP40). For immunoblotting, samples were separated on SDS polyacrylamide gel (13%) and electro-transferred onto PVDF membrane (Millipore, Missisauga, Ontario). The membrane was blocked at RT for 2 hrs with 5% Blotto, (Santa Cruz Biotechnology, CA, USA), incubated with mouse anti-FcepsilonRI-alpha chain mAbCRA-1 (1 microg/ml) at room temperature for 2 h, followed by secondary antibody HRP-goat anti-mouse IgG (H+L) prepared in TBST (1:5000). The blots were developed by enhanced chemiluminiscence as recommended by the supplier (Amersham Pharmacia,ON ).
###end p 51
###begin title 52
Statistics
###end title 52
###begin p 53
Statistical analysis was performed using GraphPad Prism Software Version 3.02 for Windows (GraphPad Software, San Diego, CA, USA). The association between levels of FcepsilonRI expression during and out of allergic season was determined by Wilcoxon signed rank test (paired, non parametric). Association between expression levels in the subgroups and cytokine stimulation effect on FcepsilonRI expression were studied using Mann-Whitney U test (unpaired non parametric).
###end p 53
###begin title 54
Supporting Information
###end title 54
###begin p 55
###xml 284 289 <span type="species:ncbi:9606">human</span>
###xml 306 311 <span type="species:ncbi:9606">human</span>
The effect of IgE on FcRI-alpha chain expression in neutrophils. Basophilic cell line (KU8112) and neutrophils from allergic asthmatics (n = 11) were stimulated or not with IgE (10mug/ml) for 24h. FcRI expression was analyzed by FACS. B-FcRI alpha chain antigen surface expression in human neutrophils and human basophilic cell line tested with quantitative indirect immunofluorescence test.
###end p 55
###begin p 56
(0.58 MB TIF)
###end p 56
###begin p 57
Click here for additional data file.
###end p 57
###begin title 58
References
###end title 58
###begin article-title 59
The mechanisms, diagnosis, and management of severe asthma in adults.
###end article-title 59
###begin article-title 60
Airway hyperresponsiveness.
###end article-title 60
###begin article-title 61
Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness.
###end article-title 61
###begin article-title 62
Influx of neutrophils into the airway lumen at 4 h after segmental allergen challenge in asthma.
###end article-title 62
###begin article-title 63
Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation.
###end article-title 63
###begin article-title 64
Increased matrix metalloproteinase-9 in the airway after allergen challenge.
###end article-title 64
###begin article-title 65
Neutrophils in asthma pathophysiology.
###end article-title 65
###begin article-title 66
Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma: Clinical and biologic significance.
###end article-title 66
###begin article-title 67
Increase in airway neutrophils after oral but not inhaled corticosteroid therapy in mild asthma.
###end article-title 67
###begin article-title 68
Association of asthma with serum IgE levels and skin-test reactivity to allergens.
###end article-title 68
###begin article-title 69
Ragweed-specific antibodies in bronchoalveolar lavage fluids and serum before and after segmental lung challenge: IgE and IgA associated with eosinophil degranulation.
###end article-title 69
###begin article-title 70
Antigen-specific IgE and IgA antibodies in bronchoalveolar lavage fluid are associated with stronger antigen-induced late phase reactions.
###end article-title 70
###begin article-title 71
The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology.
###end article-title 71
###begin article-title 72
High-affinity IgE receptor on eosinophils is involved in defence against parasites.
###end article-title 72
###begin article-title 73
Expression of functional high affinity immunoglobulin E receptors (Fc epsilon RI) on monocytes of atopic individuals.
###end article-title 73
###begin article-title 74
Peripheral blood dendritic cells express Fc epsilon RI as a complex composed of Fc epsilon RI alpha- and Fc epsilon RI gamma-chains and can use this receptor for IgE-mediated allergen presentation.
###end article-title 74
###begin article-title 75
###xml 31 36 <span type="species:ncbi:9606">human</span>
Engagement of Fc epsilon RI on human monocytes induces the production of IL-10 and prevents their differentiation in dendritic cells.
###end article-title 75
###begin article-title 76
Expression of the high-affinity receptor for IgE on bronchial epithelial cells of asthmatics.
###end article-title 76
###begin article-title 77
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human neutrophils express the high-affinity receptor for immunoglobulin E (Fc epsilon RI): role in asthma.
###end article-title 77
###begin article-title 78
###xml 84 89 <span type="species:ncbi:9606">human</span>
Characterization of monoclonal antibodies directed against the alpha-subunit of the human IgE high-affinity receptor.
###end article-title 78
###begin article-title 79
IgE modulates neutrophil survival in asthma: role of mitochondrial pathway.
###end article-title 79
###begin article-title 80
###xml 17 22 <span type="species:ncbi:9606">human</span>
IgE receptors on human basophils. Relationship to serum IgE concentration.
###end article-title 80
###begin article-title 81
###xml 110 115 <span type="species:ncbi:9606">human</span>
###xml 195 200 <span type="species:ncbi:9606">human</span>
IgE enhances Fc epsilon receptor I expression and IgE-dependent release of histamine and lipid mediators from human umbilical cord blood-derived mast cells: synergistic effect of IL-4 and IgE on human mast cell Fc epsilon receptor I expression and mediator release.
###end article-title 81
###begin article-title 82
Coordinate synthesis and degradation of the alpha-, beta- and gamma-subunits of the receptor for immunoglobulin E. Mol Immunol
###end article-title 82
###begin article-title 83
###xml 37 40 <span type="species:ncbi:10116">rat</span>
The receptor for immunoglobulin E on rat basophilic leukemia cells: effect of ligand binding on receptor expression.
###end article-title 83
###begin article-title 84
###xml 56 61 <span type="species:ncbi:9606">human</span>
Production of macrophage inflammatory protein-1alpha by human mast cells: increased anti-IgE-dependent secretion after IgE-dependent enhancement of mast cell IgE-binding ability.
###end article-title 84
###begin article-title 85
###xml 14 19 <span type="species:ncbi:10090">mouse</span>
IgE regulates mouse basophil Fc epsilon RI expression in vivo.
###end article-title 85
###begin article-title 86
###xml 13 18 <span type="species:ncbi:10090">mouse</span>
IgE enhances mouse mast cell Fc(epsilon)RI expression in vitro and in vivo: evidence for a novel amplification mechanism in IgE-dependent reactions.
###end article-title 86
###begin article-title 87
###xml 54 59 <span type="species:ncbi:9606">human</span>
In vitro regulation of FcepsilonRIalpha expression on human basophils by IgE antibody.
###end article-title 87
###begin article-title 88
###xml 87 92 <span type="species:ncbi:9606">human</span>
IgE-regulated loss, not IgE-regulated synthesis, controls expression of FcepsilonRI in human basophils.
###end article-title 88
###begin article-title 89
###xml 22 27 <span type="species:ncbi:9606">human</span>
###xml 112 117 <span type="species:ncbi:9606">human</span>
###xml 165 170 <span type="species:ncbi:9606">human</span>
Effect of recombinant human IL-4 on tryptase, chymase, and Fc epsilon receptor type I expression in recombinant human stem cell factor-dependent fetal liver-derived human mast cells.
###end article-title 89
###begin article-title 90
###xml 52 57 <span type="species:ncbi:9606">human</span>
Regulation of the high affinity receptor for IgE on human epidermal Langerhans cells.
###end article-title 90
###begin article-title 91
IL-4 upregulates Fc epsilon RI alpha-chain messenger RNA in eosinophils.
###end article-title 91
###begin article-title 92
###xml 98 103 <span type="species:ncbi:9606">human</span>
Granulocyte macrophage colony stimulating factor induces Fc epsilon RII/CD23 expression on normal human polymorphonuclear neutrophils.
###end article-title 92
###begin article-title 93
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human neutrophils synthesize IL-8 in an IgE-mediated activation.
###end article-title 93
###begin article-title 94
###xml 70 78 <span type="species:ncbi:9606">patients</span>
IgE-dependent release of myeloperoxidase by neutrophils from allergic patients.
###end article-title 94
###begin article-title 95
###xml 85 93 <span type="species:ncbi:9606">patients</span>
Specific allergens enhance elastase release in stimulated neutrophils from asthmatic patients.
###end article-title 95
###begin article-title 96
Leukemia-associated changes identified by quantitative flow cytometry. II. CD5 over-expression and monitoring in B-CLL.
###end article-title 96
###begin article-title 97
Recent developments in signal amplification methods for in situ hybridization.
###end article-title 97
###begin p 98
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 98
###begin p 99
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by grants from the Canadian Institutes of Health Research (CIHR). ASS is supported by studentships from CIHR sponsored National Training Program in Allergy and Asthma (NTPAA), Manitoba Health Research Council and the HSCF Olenick award for excellence in immunology research. The sponsors of the study had no role in study design, collection, analysis or interpretation of data, writing of the report, or in the final decision to submit this report for publication.
###end p 99

